Data-Driven Insights on European Tendering Trends
Cube RM’s analysis of 16,845 awarded batches of top biosimilars across all European countries since 2021, conducted using proprietary and tender-specific, AI-based search algorithms that crawl multiple online tender sources worldwide, provides further evidence of these trends.
The data visualized within the Cube RM platform shows that price continues to be the most important criteria when awarding tenders. However, some evolution towards tender sustainability can be observed. For instance, when examining the use of price-only versus MEAT criteria by country cluster, some interesting patterns emerge.
Annual MEAT vs Price-Only Top Biosimilars' Tenders in European Countries since 2021 Aggregated by Cluster
Countries were divided in clusters based on market strategy, i.e. which markets are prioritized in a company’s launching strategy. Cluster 1: Germany, France, Italy, Spain, and UK; Cluster 2: Denmark, Finland, Iceland, Norway, and Sweden; Cluster3: Czechia, Belgium, Ireland, Poland, and Portugal; Cluster 4: Bulgaria, Croatia, Cyprus, Estonia, Hungary, Latvia, Lithuania, Luxembourg, Malta, Romania, Slovenia, and Slovakia.
Cluster 1
In Germany, France, the UK, Italy, and Spain, MEAT criteria are becoming increasingly important in tendering processes.
Cluster 2
In Denmark, Finland, Iceland, Norway, and Sweden, MEAT represents now the main tendering practice.
Cluster 3
In Czechia, Belgium, Ireland, Poland, and Portugal, some tenders are starting to follow MEAT criteria, however price-only tenders continue to be the norm.
Cluster 4
In Bulgaria, Croatia, Cyprus, Estonia, Hungary, Latvia, Lithuania, Luxembourg, Malta, Romania, Slovenia, and Slovakia, price-only tenders also continue to represent the majority of cases.
In Focus
Germany for many years, was a typical ‘price-only’ country, driven by big national insurance tenders. However, due to recent supply challenges and shortages, we can observe an inclusion of supply-criteria in tenders in 2024.
Annual MEAT vs Price-Only Top Biosimilars' Tenders in Germany since 2021
Examples of extracted award criteria for supply in Germany